Gapping up
In reaction to earnings/guidance:
- IT +8.9%, REGI +8.8%, TRI +7%, HSC +5.6%, MYGN +5.3%, PLOW +4.5%, LNTH +4.3%, RGEN +4.3%, LEG +4.1%, CC +4%, CR +4%, NSP +3.8%, ARNC +3.7%, FI +3.5%, CBT +3.4%, RILY +3.4% (also declares $3 dividend, includes $0.50 regular and $2.50 special), LGIH +3.4%, CHGG +3.1%, UAA +3%, PINC +2.9%, VIRT +2.9%, CRSR +2.9%, CVS +2.7%, ETN +2.5%, CTLT +2.5%, NXST +2.4%, LPX +2.3%, KKR +2.2%, AGR +2%, KFRC +2%, BG +2%, COP +2%, MPC +1.7%, LTHM +1.6%, CRL +1.5%, FANG +1.4%, PFE +1.3%, AME +1.3%, RMBS +1.2%, ZI +1.2%, SU +1.1%, KMT +1.1%, BERY +1.1%, ETRN +1%, BR +1%, WMB +0.9%, APO +0.9%, WMG +0.9%
Other news:
- BLRX +59.6% (reports "positive" top-line results from GENESIS Phase 3 trial)
- VXRT +20.3% (reports data from oral COVID-19 vaccine Phase 1 study)
- UFS +16.6% (Paper Excellence said to weigh potential acquisition bid for Domtar, according to Bloomberg)
- TBBK +13.7% (to be added to S&P SmallCap 600)
- PRQR +8.2% (ProQR Therapeutics and RTW Investments announce that Yarrow Biotechnology, a company newly created by RTW, has in-licensed exclusive rights to ProQR's antisense oligonucleotide technology to develop and commercialize potential therapies for an undisclosed non-ophthalmic target)
- KYMR +6.9% (to present new pre-clinical data for KT0474)
- GAIA +4.3% (stock offering)
- UAA +3% (announces settlement with the SEC)
- KKR +2.2% (KKR raises $18.5 bln for buyout fund, according to Reuters)
- BNTX +2.1% (PFE/BNTX: FDA to authorize vaccine in adolescents 12-15 yrs old by early next week, according to NY Times)
- FANG +1.4% (OAS to acquire Williston Basin assets from FANG for $745 mln; also stock offering)
Analyst comments:
- CRNT +9.3% (upgraded to Buy from Hold at Needham)
- NTNX +3.7% (upgraded to Overweight from Neutral at JP Morgan)
- X +2.9% (upgraded to Outperform from Underperform at Credit Suisse)
- CLF +1.9% (upgraded to Outperform from Neutral at Credit Suisse)
- AAP +1.8% (upgraded to Buy from Sell at Goldman)
- CCOI +1.8% (upgraded to Outperform from Neutral at Credit Suisse)
- ON +1.1% (upgraded to Outperform from Neutral at Robert W. Baird)